Hannah Alyce Prater, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd Ste 145c, Forsyth, IL 62535 Phone: 217-876-5200 Fax: 217-876-5206 |
Dr. Michael M Wall, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd, Ste 145c, Forsyth, IL 62535 Phone: 217-876-5200 Fax: 217-876-5205 |
Dr. Roberto Pabalate, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd Ste 240, Forsyth, IL 62535 Phone: 217-876-3780 Fax: 217-876-3790 |
Dr. Maryam Qureshi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd, Suite 145d, Forsyth, IL 62535 Phone: 217-876-5250 Fax: 217-876-5255 |
Leah Marie Cummings, APRN, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 332 W Marion Ave, Forsyth, IL 62535 Phone: 217-383-0065 Fax: 217-666-9967 |
Mr. Dean Ryan Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd Ste 145a, Forsyth, IL 62535 Phone: 217-876-5270 Fax: 217-875-4001 |
Dr. Kenneth W Scribner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 241 W Weaver Rd, #190, Forsyth, IL 62535 Phone: 217-876-5240 Fax: 217-876-5245 |
News Archive
Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).
Preeclampsia is generally diagnosed later in pregnancy, but new research could lead to diagnosis in the first trimester, improving care and potentially leading to the development of preventative measures.
The "vegetable lamb" plant - once believed to bear fruit that ripened into a living baby sheep - produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease. That's the conclusion of a new study in ACS' monthly Journal of Natural Products.
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
› Verified 5 days ago